• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受基于PD-1的免疫检查点抑制治疗的黑色素瘤患者的凋亡性胃炎——临床和组织病理学发现,包括抗半胱天冬酶-3免疫组化的诊断价值

Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry.

作者信息

Placke Jan-Malte, Rawitzer Josefine, Reis Henning, Rashidi-Alavijeh Jassin, Livingstone Elisabeth, Ugurel Selma, Hadaschik Eva, Griewank Klaus, Schmid Kurt Werner, Schadendorf Dirk, Roesch Alexander, Zimmer Lisa

机构信息

Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

出版信息

Front Oncol. 2021 Aug 11;11:725549. doi: 10.3389/fonc.2021.725549. eCollection 2021.

DOI:10.3389/fonc.2021.725549
PMID:34458154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8385713/
Abstract

BACKGROUND

Gastritis induced by checkpoint inhibitors (CPI) is a rare but severe drug-related side effect. The reference standard for confirming CPI-associated gastritis (CPI-assGastritis) is histopathological assessment; however, the histopathological features of CPI-assGastritis are not yet adequately defined.

MATERIALS AND METHODS

Gastric biopsies of melanoma patients with histopathologically suspected CPI-assGastritis were compared with gastric biopsies of patients with inflammation free gastric mucosa (IFGM), type A, B, and C gastritis with respect to apoptosis count and predominant histopathological features. Immunohistochemical anti-caspase-3 staining was performed to identify apoptosis. Quantification was performed by manually counting the number of apoptotic events per 10 high-power fields (HPF). Clinical symptoms, treatment, and follow-up data of patients with CPI-assGastritis were examined. The nonparametric Mann-Whitney test was used for statistical testing.

RESULTS

Five melanoma patients (three women, two men; median age: 45 years) were treated with PD-1-based CPI. The patients reported epigastric pain, weight loss, nausea, and vomiting. Histologically, the patients with CPI-assGastritis showed a partly lymphocytic, partly granulocytic inflammatory infiltrate. Manual counting of apoptotic cells in biopsy tissue slides stained against caspase 3 revealed a median of 6 apoptotic events/10 HPF (95% CI, 2.75-17.30) in the patients with CPI-assGastritis. Results for the comparison cohort (patients n = 21) were a median of 1 apoptotic event/10 HPF (95% CI, 0.5-4.5) for type-A gastritis (six patients), a median of 2 apoptotic events/10 HPF (95% CI, 0-4.5) for type-B gastritis (five patients), and no apoptosis for IFGM and type-C gastritis (five patients). Patients with CPI-assGastritis had a significantly higher apoptosis count than patients with IFGM (p<0.01), type A (p<0.05), B (p<0.05), and C gastritis (p<0.01). None of the CPI-assGastritis biopsies showed evidence of . All CPI-assGastritis patients responded to systemic treatment with corticosteroids.

CONCLUSION

CPI-assGastritis manifests with nonspecific symptoms but histologically shows a high number of apoptotic events, which can best be visualized by anti-caspase-3 immunohistochemistry. This histopathological feature may help to histologically differentiate CPI-assGastritis from other forms of gastritis and inform decision-making regarding its optimal management.

摘要

背景

检查点抑制剂(CPI)诱发的胃炎是一种罕见但严重的药物相关副作用。确认CPI相关胃炎(CPI - assGastritis)的参考标准是组织病理学评估;然而,CPI - assGastritis的组织病理学特征尚未得到充分界定。

材料与方法

将组织病理学怀疑为CPI - assGastritis的黑色素瘤患者的胃活检组织与胃黏膜无炎症(IFGM)、A型、B型和C型胃炎患者的胃活检组织在凋亡计数和主要组织病理学特征方面进行比较。进行免疫组织化学抗半胱天冬酶 - 3染色以识别凋亡。通过手动计数每10个高倍视野(HPF)中的凋亡事件数量进行定量分析。检查CPI - assGastritis患者的临床症状、治疗和随访数据。采用非参数曼 - 惠特尼检验进行统计学检验。

结果

5例黑色素瘤患者(3例女性,2例男性;中位年龄:45岁)接受了基于PD - 1的CPI治疗。患者报告有上腹部疼痛、体重减轻、恶心和呕吐。组织学上,CPI - assGastritis患者表现为部分淋巴细胞、部分粒细胞炎性浸润。对用抗半胱天冬酶3染色的活检组织切片中的凋亡细胞进行手动计数,结果显示CPI - assGastritis患者的凋亡事件中位数为6个/10 HPF(95%CI,2.75 - 17.30)。比较队列(n = 21例患者)的结果为,A型胃炎(6例患者)凋亡事件中位数为1个/10 HPF(95%CI,0.5 - 4.5),B型胃炎(5例患者)凋亡事件中位数为2个/10 HPF(95%CI,0 - 4.5),IFGM和C型胃炎(5例患者)无凋亡。CPI - assGastritis患者的凋亡计数显著高于IFGM患者(p<0.01)、A型患者(p<0.05)、B型患者(p<0.05)和C型胃炎患者(p<0.01)。所有CPI - assGastritis活检组织均未显示……的证据。所有CPI - assGastritis患者对全身用皮质类固醇治疗均有反应。

结论

CPI - assGastritis表现为非特异性症状,但组织学上显示大量凋亡事件,通过抗半胱天冬酶 - 3免疫组织化学可最佳显示。这一组织病理学特征可能有助于在组织学上将CPI - assGastritis与其他形式的胃炎区分开来,并为其最佳管理的决策提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/ac371119e0dc/fonc-11-725549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/8570ea3729e6/fonc-11-725549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/53c577f80114/fonc-11-725549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/771fea98924f/fonc-11-725549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/e12329fff7ea/fonc-11-725549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/8ec98ae1eaf5/fonc-11-725549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/ac371119e0dc/fonc-11-725549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/8570ea3729e6/fonc-11-725549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/53c577f80114/fonc-11-725549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/771fea98924f/fonc-11-725549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/e12329fff7ea/fonc-11-725549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/8ec98ae1eaf5/fonc-11-725549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2d/8385713/ac371119e0dc/fonc-11-725549-g006.jpg

相似文献

1
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry.接受基于PD-1的免疫检查点抑制治疗的黑色素瘤患者的凋亡性胃炎——临床和组织病理学发现,包括抗半胱天冬酶-3免疫组化的诊断价值
Front Oncol. 2021 Aug 11;11:725549. doi: 10.3389/fonc.2021.725549. eCollection 2021.
2
The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.幽门螺杆菌毒力因子与 PD1:PD-L1 免疫检查点抑制剂在胃癌进展中的相互作用。
Immunol Lett. 2021 Nov;239:1-11. doi: 10.1016/j.imlet.2021.06.009. Epub 2021 Aug 5.
3
Pathologic Manifestations of Gastrointestinal and Hepatobiliary Injury in Immune Checkpoint Inhibitor Therapy.免疫检查点抑制剂治疗中胃肠道和肝胆损伤的病理表现。
Arch Pathol Lab Med. 2021 May 1;145(5):571-582. doi: 10.5858/arpa.2020-0070-RA.
4
Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis.肥大细胞在幽门螺杆菌引起的胃炎中的作用:在上皮细胞凋亡中的潜在作用。
J Clin Pathol. 2007 Jun;60(6):600-7. doi: 10.1136/jcp.2006.040741.
5
[Diagnosis of Helicobacter pylori infection on gastric biopsies: Standard stain, special stain or immunohistochemistry?].[胃活检中幽门螺杆菌感染的诊断:标准染色、特殊染色还是免疫组织化学?]
Ann Pathol. 2018 Dec;38(6):363-369. doi: 10.1016/j.annpat.2018.03.009. Epub 2018 May 28.
6
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis.免疫检查点抑制剂诱发垂体炎的临床表现、影像学表现及 HLA 类型谱
J Endocr Soc. 2023 Feb 6;7(4):bvad012. doi: 10.1210/jendso/bvad012. eCollection 2023 Feb 9.
7
Nodular gastritis in adults: clinical features, endoscopic appearance, histopathological features, and response to therapy.成人结节性胃炎:临床特征、内镜表现、组织病理学特征及治疗反应
J Gastroenterol Hepatol. 2008 Jun;23(6):943-7. doi: 10.1111/j.1440-1746.2007.05044.x. Epub 2007 Jul 6.
8
Grading Helicobacter pylori gastritis in dyspeptic patients.消化不良患者幽门螺杆菌胃炎的分级
Comp Immunol Microbiol Infect Dis. 1996 Feb;19(2):147-54. doi: 10.1016/0147-9571(95)00028-3.
9
Foveolar cells phagocytose apoptotic neutrophils in chronic active Helicobacter pylori gastritis.胃黏膜固有层滤泡细胞吞噬慢性活动性幽门螺杆菌胃炎中的凋亡中性粒细胞。
Virchows Arch. 2012 Nov;461(5):489-94. doi: 10.1007/s00428-012-1308-x. Epub 2012 Sep 5.
10
Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patient.一名黑色素瘤患者中,抗程序性死亡蛋白1(PD-1)药物帕博利珠单抗诱发的自身免疫性胃炎。
Acta Gastroenterol Belg. 2020 Jul-Sep;83(3):482-484.

引用本文的文献

1
Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer.幽门螺杆菌感染对胃癌免疫检查点抑制剂疗效的影响。
BMC Cancer. 2025 Jul 1;25(1):1101. doi: 10.1186/s12885-025-14436-x.
2
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.免疫检查点抑制剂相关的胃肠道、肝胆和胰腺不良事件的系统评价。
J Immunother Cancer. 2024 Nov 14;12(11):e009742. doi: 10.1136/jitc-2024-009742.
3
A systematic review of gastritis as an immune-related adverse event in clinical interventions.

本文引用的文献

1
Severe steroid refractory gastritis induced by Nivolumab: A case report.纳武利尤单抗致严重类固醇难治性胃炎 1 例报告
World J Gastroenterol. 2020 Apr 28;26(16):1971-1978. doi: 10.3748/wjg.v26.i16.1971.
2
Morphological spectrum of immune check-point inhibitor therapy-associated gastritis.免疫检查点抑制剂治疗相关胃炎的形态谱。
Histopathology. 2020 Mar;76(4):531-539. doi: 10.1111/his.14029. Epub 2020 Feb 18.
3
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤的 5 年生存数据
系统评价胃炎作为临床干预的免疫相关不良事件。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408852. doi: 10.1080/21645515.2024.2408852. Epub 2024 Oct 21.
4
A case of gastritis caused by immune checkpoint inhibitor treated with infliximab.1例接受英夫利昔单抗治疗的免疫检查点抑制剂所致胃炎病例。
Int Cancer Conf J. 2024 Sep 18;13(4):454-459. doi: 10.1007/s13691-024-00709-y. eCollection 2024 Oct.
5
Clinical Characteristics and Outcomes of Pembrolizumab Induced Gastritis: A Systematic Review of the Literature.帕博利珠单抗相关性胃炎的临床特征和结局:文献系统评价。
J Gastrointest Cancer. 2024 Sep;55(3):1-8. doi: 10.1007/s12029-024-01067-x. Epub 2024 May 24.
6
Immune checkpoint inhibitor-associated gastritis: Patterns and management.免疫检查点抑制剂相关性胃炎:模式与管理。
World J Gastroenterol. 2024 Apr 14;30(14):1941-1948. doi: 10.3748/wjg.v30.i14.1941.
7
Clinical characteristics, diagnosis, treatment, and prognosis of nivolumab induced gastritis.纳武利尤单抗诱导性胃炎的临床特征、诊断、治疗和预后。
Invest New Drugs. 2024 Feb;42(1):53-59. doi: 10.1007/s10637-023-01412-0. Epub 2023 Dec 8.
8
Nivolumab-induced tumour-like gastritis: A case report.纳武利尤单抗诱导的肿瘤样胃炎:一例报告。
World J Clin Cases. 2023 Jun 26;11(18):4350-4359. doi: 10.12998/wjcc.v11.i18.4350.
9
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy.接受免疫治疗的癌症患者中与免疫相关的罕见不良事件
Diagnostics (Basel). 2022 Aug 29;12(9):2091. doi: 10.3390/diagnostics12092091.
N Engl J Med. 2019 Oct 17;381(16):1535-1546. doi: 10.1056/NEJMoa1910836. Epub 2019 Sep 28.
4
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.纳武利尤单抗联合伊匹单抗治疗晚期非小细胞肺癌。
N Engl J Med. 2019 Nov 21;381(21):2020-2031. doi: 10.1056/NEJMoa1910231. Epub 2019 Sep 28.
5
A Cell's Fate: An Overview of the Molecular Biology and Genetics of Apoptosis.细胞的命运:细胞凋亡的分子生物学和遗传学概述。
Int J Mol Sci. 2019 Aug 24;20(17):4133. doi: 10.3390/ijms20174133.
6
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.纳武利尤单抗联合伊匹单抗对比舒尼替尼用于晚期肾细胞癌的一线治疗:来自一项随机、对照、III 期临床试验的疗效和安全性结果的扩展随访。
Lancet Oncol. 2019 Oct;20(10):1370-1385. doi: 10.1016/S1470-2045(19)30413-9. Epub 2019 Aug 16.
7
Gastrointestinal Biopsies for Evaluation of Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Patients.用于评估异基因造血干细胞移植患者急性移植物抗宿主病的胃肠道活检
Indian J Hematol Blood Transfus. 2019 Jan;35(1):83-88. doi: 10.1007/s12288-018-0969-2. Epub 2018 Jun 9.
8
Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma.帕博利珠单抗诱发的转移性黑色素瘤患者淋巴细胞性胃炎
Melanoma Res. 2018 Dec;28(6):645-647. doi: 10.1097/CMR.0000000000000502.
9
Severe Gastritis after Administration of Nivolumab and Ipilimumab.纳武单抗和伊匹单抗给药后出现的严重胃炎。
Case Rep Oncol. 2018 Aug 17;11(2):549-556. doi: 10.1159/000491862. eCollection 2018 May-Aug.
10
Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective.免疫检查点抑制剂相关的胃肠道和肝脏损伤:病理学家的视角。
J Clin Pathol. 2018 Aug;71(8):665-671. doi: 10.1136/jclinpath-2018-205143. Epub 2018 Apr 27.